| CD38-NAD+ axis regulates immunotherapeutic anti-tumor T cell response S Chatterjee, A Daenthanasanmak, P Chakraborty, MW Wyatt, P Dhar, ... Cell metabolism 27 (1), 85-100. e8, 2018 | 227 | 2018 |
| Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation HD Nguyen, S Chatterjee, KMK Haarberg, Y Wu, D Bastian, J Heinrichs, ... The Journal of clinical investigation 126 (4), 1337-1352, 2016 | 128 | 2016 |
| A quantitative increase in regulatory T cells controls development of vitiligo S Chatterjee, JM Eby, AA Al-Khami, M Soloshchenko, HK Kang, N Kaur, ... Journal of Investigative Dermatology 134 (5), 1285-1294, 2014 | 101 | 2014 |
| A novel copper complex induces ROS generation in doxorubicin resistant Ehrlich ascitis carcinoma cells and increases activity of antioxidant enzymes in vital organs in vivo A Mookerjee, JM Basu, S Majumder, S Chatterjee, GS Panda, P Dutta, ... BMC cancer 6, 1-11, 2006 | 81 | 2006 |
| The role of copper in drug-resistant murine and human tumors S Majumder, S Chatterjee, S Pal, J Biswas, T Efferth, SK Choudhuri Biometals 22, 377-384, 2009 | 78 | 2009 |
| CCL22 to activate Treg migration and suppress depigmentation in vitiligo JM Eby, HK Kang, ST Tully, WE Bindeman, DS Peiffer, S Chatterjee, ... Journal of Investigative Dermatology 135 (6), 1574-1580, 2015 | 72 | 2015 |
| Pro-survival lipid sphingosine-1-phosphate metabolically programs T cells to limit anti-tumor activity P Chakraborty, SG Vaena, K Thyagarajan, S Chatterjee, A Al-Khami, ... Cell reports 28 (7), 1879-1893. e7, 2019 | 70 | 2019 |
| Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial Y Ray, SR Paul, P Bandopadhyay, R D’Rozario, J Sarif, A Lahiri, ... MedRxiv, 2020.11. 25.20237883, 2020 | 68 | 2020 |
| Nature and dimensions of systemic hyperinflammation and its attenuation by convalescent plasma in severe COVID-19 P Bandopadhyay, R D’Rozario, A Lahiri, J Sarif, Y Ray, SR Paul, R Roy, ... The Journal of infectious diseases 224 (4), 565-574, 2021 | 64* | 2021 |
| Reducing CD73 expression by IL1β-Programmed Th17 cells improves immunotherapeutic control of tumors S Chatterjee, K Thyagarajan, P Kesarwani, JH Song, M Soloshchenko, ... Cancer research 74 (21), 6048-6059, 2014 | 64 | 2014 |
| CD38: T cell immuno-metabolic modulator A Kar, S Mehrotra, S Chatterjee Cells 9 (7), 1716, 2020 | 60 | 2020 |
| A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells S Chatterjee, A Mookerjee, J Mookerjee Basu, P Chakraborty, A Ganguly, ... PLoS One 4 (9), e7048, 2009 | 57 | 2009 |
| Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naive CD4+ T cells S Chatterjee, S Das, P Chakraborty, A Manna, M Chatterjee, ... Immunobiology 218 (5), 718-724, 2013 | 51 | 2013 |
| Targeting PIM kinase with PD1 inhibition improves immunotherapeutic antitumor T-cell response S Chatterjee, P Chakraborty, A Daenthanasanmak, S Iamsawat, ... Clinical cancer research 25 (3), 1036-1049, 2019 | 50 | 2019 |
| Targeting mitochondrial cell death pathway to overcome drug resistance with a newly developed iron chelate A Ganguly, S Basu, P Chakraborty, S Chatterjee, A Sarkar, M Chatterjee, ... PLoS One 5 (6), e11253, 2010 | 50 | 2010 |
| Ccl22 diverts T regulatory cells and controls the growth of melanoma J Klarquist, K Tobin, P Farhangi Oskuei, SW Henning, MF Fernandez, ... Cancer research 76 (21), 6230-6240, 2016 | 49 | 2016 |
| Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing JH Song, N An, S Chatterjee, E Kistner-Griffin, S Mahajan, S Mehrotra, ... Oncogene 34 (28), 3728-3736, 2015 | 47 | 2015 |
| Reprogramming of TAM toward proimmunogenic type through regulation of MAP kinases using a redox-active copper chelate P Chakraborty, S Chatterjee, A Ganguly, P Saha, A Adhikary, T Das, ... Journal of leukocyte biology 91 (4), 609-619, 2012 | 44 | 2012 |
| Immune responses in a mouse model of vitiligo with spontaneous epidermal de‐and repigmentation JM Eby, HK Kang, J Klarquist, S Chatterjee, JA Mosenson, MI Nishimura, ... Pigment cell & melanoma research 27 (6), 1075-1085, 2014 | 37 | 2014 |
| Lack of p53 augments antitumor functions in cytolytic T cells A Banerjee, K Thyagarajan, S Chatterjee, P Chakraborty, P Kesarwani, ... Cancer research 76 (18), 5229-5240, 2016 | 36 | 2016 |
